First Time Loading...

Mediclinic International PLC
LSE:MDC

Watchlist Manager
Mediclinic International PLC Logo
Mediclinic International PLC
LSE:MDC
Watchlist
Price: 501 GBX Market Closed
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

7.9B
+9%
Assets
Growth Rates:
1 Year
+12%
3 Years
+7%
5 Years
+13%
7 Years
-
10 Years
-
4.3B
+6%
Liabilities
Growth Rates:
1 Year
+9%
3 Years
+8%
5 Years
+39%
7 Years
-
10 Years
-
3.5B
+14%
Equity
Growth Rates:
1 Year
+17%
3 Years
+6%
5 Years
-8%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Mediclinic International PLC

7.9B
Assets
4.3B
Liabilities
7.9B
Assets
4.3B
Liabilities
Current Assets 1.6B
Cash & Short-Term Investments 454m
Receivables 989m
Other Current Assets 110m
Non-Current Assets 6.3B
Long-Term Investments 194m
PP&E 4.8B
Intangibles 1.3B
Other Non-Current Assets 34m
Current Liabilities 1B
Accounts Payable 625m
Accrued Liabilities 25m
Other Current Liabilities 395m
Non-Current Liabilities 3.3B
Long-Term Debt 2.5B
Other Non-Current Liabilities 762m

Balance Sheet
Mediclinic International PLC

Rotate your device to view
Balance Sheet
Currency: GBP
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022
Assets
Cash & Cash Equivalents
265
305
361
261
265
329
294
534
Cash
0
0
0
0
0
0
0
0
Cash Equivalents
265
305
361
261
265
329
294
534
Short-Term Investments
11
0
16
1
1
2
2
6
Total Receivables
417
549
593
608
733
730
780
778
Accounts Receivables
293
380
425
440
516
562
718
722
Other Receivables
124
169
168
168
217
168
62
56
Inventory
60
75
90
90
88
104
109
97
Other Current Assets
0
2
9
1
4
48
47
59
Total Current Assets
742
931
1 069
961
1 091
1 213
1 232
1 474
PP&E Net
2 985
3 199
3 703
3 590
3 524
4 358
4 052
4 385
PP&E Gross
2 985
3 199
3 703
3 590
3 524
4 358
4 052
4 385
Accumulated Depreciation
518
649
846
998
1 321
1 595
1 647
1 946
Intangible Assets
333
409
441
153
136
124
115
119
Goodwill
309
1 532
1 715
1 253
1 451
1 047
946
1 007
Note Receivable
0
0
0
0
0
0
0
0
Long-Term Investments
9
461
473
364
203
190
183
189
Other Long-Term Assets
18
17
21
22
23
22
144
33
Other Assets
309
1 532
1 715
1 253
1 451
1 047
946
1 007
Total Assets
4 396
N/A
6 549
+49%
7 422
+13%
6 343
-15%
6 428
+1%
6 954
+8%
6 672
-4%
7 207
+8%
Liabilities
Accounts Payable
157
200
227
210
230
260
235
263
Accrued Liabilities
54
64
80
72
54
57
60
65
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
68
317
69
71
87
213
146
171
Other Current Liabilities
163
206
214
172
215
239
243
324
Total Current Liabilities
442
787
590
525
586
769
684
823
Long-Term Debt
1 550
1 524
1 961
1 866
1 895
2 441
2 307
2 418
Deferred Income Tax
429
446
527
467
423
427
425
432
Minority Interest
61
61
78
87
115
113
118
139
Other Liabilities
135
222
180
112
258
314
289
288
Total Liabilities
2 617
N/A
3 040
+16%
3 336
+10%
3 057
-8%
3 277
+7%
4 064
+24%
3 823
-6%
4 100
+7%
Equity
Common Stock
994
74
74
74
74
74
74
74
Retained Earnings
808
2 747
3 324
2 523
2 387
1 319
1 515
1 593
Additional Paid In Capital
0
690
690
690
690
690
690
690
Treasury Stock
23
0
2
1
0
0
0
0
Other Equity
0
0
0
0
0
807
570
750
Total Equity
1 779
N/A
3 509
+97%
4 086
+16%
3 286
-20%
3 151
-4%
2 890
-8%
2 849
-1%
3 107
+9%
Total Liabilities & Equity
4 396
N/A
6 549
+49%
7 422
+13%
6 343
-15%
6 428
+1%
6 954
+8%
6 672
-4%
7 207
+8%
Shares Outstanding
Common Shares Outstanding
542
737
737
737
737
737
737
737

See Also

Summary
MDC intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDC stock valuation using valuation multiples.
Wall Street Estimates
MDC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.